Surgery Partners Surges as $5.7 Billion Deal Takes Company Private

What happened

Surgery Partners, an outpatient surgery operator, agreed to be taken private by HealthSpan Partners for $5.7 billion. Public shareholders, excluding Bain Capital affiliates, will receive $23.50 per share in cash and the deal is expected to close in the first quarter of 2027.

Confirmed

Global impact / market context

The takeover ends Surgery Partners' time as a publicly traded company, so its shares will stop trading on Nasdaq and become privately held. Bain Capital, which owns about 39%, keeps a stake, showing continued investor support for outpatient surgery businesses.

Analyst inference

HealthSpan plans to pay with cash on hand and new debt and has secured financing, so the buyer relies on borrowed money that must be repaid. Because the deal is not conditional on financing, the main remaining hurdles are shareholder and regulatory approvals.

Analyst inference

What to watch

1. Shareholders must approve the merger by a majority of outstanding shares and a majority of votes cast by disinterested shareholders, which means investors without a conflict of interest must also back the deal. Confirmed
2. The agreement includes a $108.99 million termination fee under specified circumstances and an outside closing date of July 23, 2027, subject to certain extensions, so either can matter if the deal stalls. Confirmed
3. HealthSpan's use of new debt means the private company will carry borrowed money, so its future cash available and ability to fund capital spending at outpatient surgery centers will depend on repaying that debt. Analyst inference

Evidence

• Original source link unavailable